Dr. Lange is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
800A Fifth Ave (at 61st)
Suite 203
New York, NY 10065- Is this information wrong?
Summary
- Dr. Dale Lange is a neurologist in New York, NY and is affiliated with New York-Presbyterian Hospital/Weill Cornell Medicine. He received his medical degree from New York Medical College and has been in practice for more than 35 year years. He specializes in neuromuscular medicine and is experienced in general neurology, ALS, CIDP, myasthenia gravis, polymyositis, muscular dystrophy, spinal cord disorders. muscular dystrophy and all nerve and muscle disorders. He has more than 100 publications and over 500 citings.
Education & Training
Tufts Medical CenterResidency, Neurology, 1979 - 1982
Albany Medical CenterInternship, Internal Medicine, 1978 - 1979
New York Medical CollegeClass of 1978
Certifications & Licensure
NY State Medical License 1982 - 2025- American Board of Psychiatry and Neurology Neurology
- American Board of Psychiatry and Neurology Neuromuscular Medicine
Awards, Honors, & Recognition
- Top Doctors: New York Metro Area Castle Connolly, 2007-2014
- Super Doctor SuperDoctors.com
Clinical Trials
- SOD1 Inhibition by Pyrimethamine in Familial Amyotrophic Lateral Sclerosis (ALS) Start of enrollment: 2009 Nov 01
- Diaphragm Pacing System (DPS) In Participants With Amyotrophic Lateral Sclerosis (ALS) Start of enrollment: 2013 Aug 01
- Clinical Trial of Ezogabine (Retigabine) in ALS Subjects Start of enrollment: 2015 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- 8 citationsSafety and efficacy of oral levosimendan in people with amyotrophic lateral sclerosis (the REFALS study): a randomised, double-blind, placebo-controlled phase 3 trial.Merit Cudkowicz, Angela Genge, Nicholas J. Maragakis, Susanne Petri, Leonard H. van den Berg, Valtteri V Aho, Toni Sarapohja, Mikko Kuoppamäki, Chris Garratt, Ammar Al...> ;The Lancet. Neurology. 2021 Oct 1
- 6 citationsA specific biomarker for amyotrophic lateral sclerosis: Quantitative susceptibility mapping.Kathryn E. Dean, Beiyi Shen, Gulce Askin, Andrew D. Schweitzer, Mona Shahbazi, Yi Wang, Dale J. Lange, Apostolos John Tsiouris> ;Clinical Imaging. 2021 Jan 4
- 6 citationsHeuristic scoring method utilizing FDG-PET statistical parametric mapping in the evaluation of suspected Alzheimer disease and frontotemporal lobar degeneration.Jeremy N Ford, Elizabeth M. Sweeney, Myrto Skafida, Shannon M. Glynn, Michael Amoashiy, Dale J. Lange, Eaton Lin, Gloria C. Chiang, Joseph R. Osborne, Silky Pahlajani,...> ;American Journal of Nuclear Medicine and Molecular Imaging. 2021 Jan 1
- Join now to see all
Press Mentions
What Can Cannabis Do for Patients with ALS?July 27th, 2019
Onetime Malaria Therapy Pyrimethamine Reduces Levels of ALS-Linked Protein, Study FindsJune 21st, 2017
Drug Found to Lower Levels of Biomarker Linked to ALSJune 12th, 2017- Join now to see all
Professional Memberships
- Member
Hospital Affiliations
New York-Presbyterian HospitalNew York, New York
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
